Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0664 CHF | 0.00% | -2.64% | +44.35% |
04:00pm | Transcript : Addex Therapeutics Ltd, Q1 2024 Earnings Call, Jun 06, 2024 | |
10:03am | Addex Therapeutics' Q1 Net Loss Widens; Revenue Down | MT |
Business Summary
Number of employees: 23
Sales per Business
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Small-molecule Pharmaceutical Products
100.0
%
| 1 | 100.0 % | 2 | 100.0 % | +13.99% |
Sales per region
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Switzerland
100.0
%
| 1 | 100.0 % | 2 | 100.0 % | +13.99% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Tim Dyer
FOU | Founder | 56 | 01-12-31 |
Lénaic Teyssédou
DFI | Director of Finance/CFO | 38 | 17-05-31 |
Vincent Lawton
CHM | Chairman | 75 | 09-04-15 |
Roger G. Mills
CTO | Chief Tech/Sci/R&D Officer | 67 | 16-11-27 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jake Nunn
BRD | Director/Board Member | 53 | 18-05-31 |
Tim Dyer
FOU | Founder | 56 | 01-12-31 |
Vincent Lawton
CHM | Chairman | 75 | 09-04-15 |
Roger G. Mills
CTO | Chief Tech/Sci/R&D Officer | 67 | 16-11-27 |
Isaac Manke
BRD | Director/Board Member | 47 | 17-12-31 |
Ray Hill
BRD | Director/Board Member | 79 | 08-04-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 181,952,457 | 89,968,982 ( 49.45 %) | 59,159,103 ( 32.51 %) | 49.45 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
ADDEX THERAPEUTICS LTD 23.93% | 44,113,438 | 23.93% | 2,933,985 $ |
Company contact information
Addex Therapeutics Ltd.
9, Chemin des Mines Plan-les-Ouates
1202, Geneva
+41 22 884 1555
http://www.addextherapeutics.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.35% | 9.52M | |
+57.65% | 59.34B | |
+43.17% | 40.24B | |
-5.43% | 39.88B | |
-5.56% | 28.55B | |
+15.37% | 27.26B | |
-21.09% | 19.23B | |
+33.28% | 12.61B | |
+2.36% | 12.49B | |
+25.51% | 12.28B |
- Stock Market
- Equities
- ADXN Stock
- Company Addex Therapeutics Ltd